The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP2 Portfolio I
Overview of the EDCTP2 portfolio of Collaborative Research & Development projects 2014-2019. profiles for each project.
EDCTP2 Portfolio II
Overview of the EDCTP2 Portfolio: Fellowship programme 2014-2019. Profiles for each fellowship.
Webinar 27/01/20
EDCTP and CEPI streamline the procedures for their future grants for Lassa Fever Vaccines trials. Essential webinar on requirements.
Free registration needed.
Latest news
PanACEA 2: New TB drug tested in patients for the first time in South Africa
The new promising tuberculosis drug BTZ-043 has been administered to patients for the first time in Cape Town, South Africa. This clinical study which is led by Professor Michael Hoeslcher of the Tropical Institute at the Hospital of the Ludwig-Maximilians…
World AIDS day 2019: Clinical research that reaches key populations
According to World Health Organization (WHO) statistics, in 2018 an estimated 1.7 million people were newly infected with HIV and there were 0.8 million HIV-related deaths. Most of these deaths are in low and middle-income countries, particularly in sub-Saharan Africa,…